Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 749 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Salt Lake City Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Virginia - Carolinas Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Pennsylvania Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Associate Director, Data Scientist (Human Genetics) Regular, Full time | Research | Switzerland | Basel (City) | Dec 02, 2025 |
| Director Oncology Data Science LMW Regular, Full time | Research | USA | Cambridge (USA) | Dec 02, 2025 |
| AD, Integrated Field Execution Effectiveness Regular, Full time | General Management | USA | East Hanover | Dec 02, 2025 |
| Manager - Customer Data Platform Regular, Full time | Marketing | India | Hyderabad (Office) | Dec 02, 2025 |
| AD, Integrated Field Deployment and GTM Analytics - IMM Regular, Full time | General Management | USA | East Hanover | Dec 02, 2025 |
| Associate Director, DDIT M&A Deal Enablement,Technical Business Analyst Regular, Full time | Information Technology | Czech Republic | Prague | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Boston, MA Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
Pagination
- ‹ Previous page
- 1
- …
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- …
- 75
- › Next page
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى